Literature DB >> 24094319

Toward the development of a global induced pluripotent stem cell library.

Marc Turner1, Stephen Leslie, Nicholas G Martin, Marc Peschanski, Mahendra Rao, Craig J Taylor, Alan Trounson, David Turner, Shinya Yamanaka, Ian Wilmut.   

Abstract

The ability to preselect the donor genotype of iPSC lines provides important opportunities for immune matching in cell therapy. Here we propose that an international assessment should be made of how immune incompatibility can best be managed and how a network of GMP HLA homozygous haplobanks could be operated.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Year:  2013        PMID： 24094319     DOI： 10.1016/j.stem.2013.08.003

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN： 1875-9777            Impact factor:   24.633


  93 in total

Review 1.  Tissue Engineering and Regenerative Medicine 2015: A Year in Review.

Authors:  Holly Wobma; Gordana Vunjak-Novakovic
Journal:  Tissue Eng Part B Rev       Date:  2016-02-23       Impact factor: 6.389

2.  Developing Induced Pluripotent Stem Cell-Based Therapy for the Masses.

Authors:  Mahendra S Rao; Anthony Atala
Journal:  Stem Cells Transl Med       Date:  2015-12-30       Impact factor: 6.940

Review 3.  Cellular and Molecular Aspects of Parkinson Treatment: Future Therapeutic Perspectives.

Authors:  Khosro Jamebozorgi; Eskandar Taghizadeh; Daryoush Rostami; Hosein Pormasoumi; George E Barreto; Seyed Mohammad Gheibi Hayat; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-11-05       Impact factor: 5.590

4.  CASMI TSCC launch event, Paris, France, July 2013: an assessment of the key barriers to the commercialization and clinical adoption of pluripotent stem cell therapies.

Authors:  Anna French; Kim Bure; David A Brindley
Journal:  Rejuvenation Res       Date:  2014-02       Impact factor: 4.663

Review 5.  New cell sources for T cell engineering and adoptive immunotherapy.

Authors:  Maria Themeli; Isabelle Rivière; Michel Sadelain
Journal:  Cell Stem Cell       Date:  2015-04-02       Impact factor: 24.633

Review 6.  Concise review: making and using clinically compliant pluripotent stem cell lines.

Authors:  Melissa K Carpenter; Mahendra S Rao
Journal:  Stem Cells Transl Med       Date:  2015-02-26       Impact factor: 6.940

Review 7.  Induced Pluripotent Stem Cell-Derived Endothelial Cells: Overview, Current Advances, Applications, and Future Directions.

Authors:  Sae Jang; Alexandra Collin de l'Hortet; Alejandro Soto-Gutierrez
Journal:  Am J Pathol       Date:  2019-01-14       Impact factor: 4.307

8.  Translational strategies and challenges in regenerative medicine.

Authors:  Stefanie Dimmeler; Sheng Ding; Thomas A Rando; Alan Trounson
Journal:  Nat Med       Date:  2014-08       Impact factor: 53.440

9.  Harmonizing standards for producing clinical-grade therapies from pluripotent stem cells.

Authors:  Peter W Andrews; Joy Cavagnaro; Joy Cavanagro; Robert Deans; Ellen Feigal; Ellen Feigel; Ed Horowitz; Armand Keating; Mahendra Rao; Marc Turner; Ian Wilmut; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2014-08       Impact factor: 54.908

Review 10.  Modulation of human allogeneic and syngeneic pluripotent stem cells and immunological implications for transplantation.

Authors:  S D Sackett; M E Brown; D M Tremmel; T Ellis; W J Burlingham; J S Odorico
Journal:  Transplant Rev (Orlando)       Date:  2016-02-10       Impact factor: 3.943
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.